NCT06074263 (SAILS-Steroid) is a Phase 4 clinical trial of Dexamethasone 8mg in Pain Management, sponsored by Rutgers, The State University of New Jersey.

Who is sponsoring NCT06074263?

NCT06074263 is sponsored by Rutgers, The State University of New Jersey.

What drugs are being tested in NCT06074263?

Interventions in NCT06074263: Dexamethasone 8mg, Placebo.

What condition does NCT06074263 study?

NCT06074263 studies Pain Management.

Is NCT06074263 still recruiting?

NCT06074263 is currently terminated. Last updated 4 June 2025.

Last reviewed 2025-06-04 · How we verify

NCT06074263: SAILS-Steroid

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Search to Advance Limited Use of Opioids Pilot: Optimization of Non-Opioid Therapy With a Steroid

Terminated Phase 4 Last updated 4 June 2025

What this trial tests

Phase 4 trial testing Dexamethasone 8mg in Pain Management in 8 participants. Terminated before completion.

Timeline

27 November 2023

Primary endpoint
30 September 2024

31 December 2024

Quick facts

Lead sponsor	Rutgers, The State University of New Jersey
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	8
Start date	27 November 2023
Primary completion	30 September 2024
Estimated completion	31 December 2024
Sites	1 location across United States

Drugs / interventions tested

Dexamethasone 8mg — full drug profile →
Placebo

Conditions studied

Pain Management — all drugs for Pain Management →

Sponsor

Rutgers, The State University of New Jersey

Who can join

Adults 18 to 99, any sex, with Pain Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To provide health care professionals, including dentists, with the best possible evidence for clinical decision making when deciding upon analgesics and use of corticosteroid for acute post-surgical pain management; a pilot double blind randomized clinical trial will be conducted to test the hypothesis that use of preemptive dose of corticosteroid will reduce the need for opioid rescue. The impacted 3rd molar extraction model will be used due to the predictable severity of the post-operative pain and generalizability of results, as well as the fact that dentists write about one third of opioid prescriptions for adolescents.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain Management

Currently open trials in the same condition.

NCT07369024 — Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults · Phase 2 · recruiting
NCT07410000 — Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
NCT07442539 — The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery · NA · recruiting

Other Rutgers, The State University of New Jersey trials

Trials by the same sponsor.

NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06074263 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 4 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06074263.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing